IQGAP1 and acute myeloid leukemia: In addition, UR778Br also inhibited the viability and colony formation of human primary AML cells without affecting normal bone marrow cells, which suggests that targeting IQGAP1 may result in lower hematologic toxicities than cytotoxic chemotherapy.